SIRT3 expression as a biomarker for better prognosis in gastric cancer

Kuo Hung Huang, Chia Chi Hsu, Wen Liang Fang, Chin Wen Chi, Ming Ta Sung, Hwa Li Kao, Anna Fen Yau Li, Pen Hui Yin, Muh Hwa Yang*, Hsin Chen Lee

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

35 Scopus citations


Background: SIRT3 - mitochondrial nicotinamide adenine dinucleotide- dependent deacetylase sirtuin-3 - plays an important role in regulating cell metabolism and carcinogenesis. The role of SIRT3 in gastric cancer has not yet been investigated. Methods: A total of 221 gastric cancer patients who underwent curative surgery were enrolled at the Department of Surgery, Taipei Veterans General Hospital. SIRT3 expression in gastric tissues and tumors were examined in these patients using immunohistochemical staining. Clinicopathologic characteristics and survival were analyzed and compared in gastric cancer patients with or without SIRT3 expression. Results: The 5-year survival rates of patients with or without SIRT3 expression were 51.2 and 39.1 %, respectively (p = 0.005). The 5-year disease-free survival rates of patients with or without SIRT3 expression were 49.6 and 38.0 %, respectively (p = 0.010). Microscopic features showed that there are more poor cell differentiation (p = 0.001), more diffuse-type Lauren's histology (p = 0.018), and more scirrhous-type stromal reactions (p = 0.027) in gastric cancer without SIRT expression. Multivariate analysis with overall survival as an endpoint showed that age (p < 0.001), Lauren's histology (p = 0.007), stromal reaction (p = 0.035), TNM pathologic N category (p < 0.001), and SIRT3 expression (p < 0.001) were significantly correlated with gastric cancer. Conclusions: Gastric cancer patients with SIRT3 expression have a better prognosis than those without. SIRT3 expression is an independent prognostic marker for overall survival and may act as a tumor suppressor in gastric cancer.

Original languageEnglish
Pages (from-to)910-917
Number of pages8
JournalWorld Journal of Surgery
Issue number4
StatePublished - Apr 2014


Dive into the research topics of 'SIRT3 expression as a biomarker for better prognosis in gastric cancer'. Together they form a unique fingerprint.

Cite this